Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031-Reference-Cited by-同舟云学术

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031

Published:2011-02 Issue:2 Volume:22 Page:348-354
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Picozzi V.J.,Abrams R.A.,Decker P.A.,Traverso W.,O'Reilly E.M.,Greeno E.,Martin R.C.,Wilfong L.S.,Rothenberg M.L.,Posner M.C.,Pisters P.W.T.

Funder

U.S. National Institutes of Health to the American College of Surgeons Oncology Group

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/2/348/407521/mdq384.pdf

Reference22 articles.

1. Adjuvant therapy for pancreatic cancer;Ghaneh;World J Surg,1999

2. Adjuvant radio-therapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region;Klinkenbijl;Ann Surg,1999

3. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer;Neoptolemos;N Engl J Med,2004

4. Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreas cancer: a randomized controlled trial;Oettle;JAMA,2007

5. ESPAC-3(v2): a multicenter, international, open-label randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid versus gemcitabine in patients with resected pancreas cancer;Neoptolemos;J Clin Oncol,2009

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Cisplatin-Containing Chemotherapy Regimens in Patients of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis;Journal of Gastrointestinal Cancer;2024-02-05

2. Immune modulation during anti-cancer radio(immuno)therapy;International Review of Cell and Molecular Biology;2024

3. The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer;Frontiers in Oral Health;2023-07-11

4. Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?;Cancers;2023-01-26

5. C9orf16 represents the aberrant genetic programs and drives the progression of PDAC;BMC Cancer;2022-10-28